Al-Dawaa Medical Services Company (TADAWUL: 4163)

Market Cap	6.55B
Revenue (ttm)	6.19B
Net Income (ttm)	358.65M
Shares Out	85.00M
EPS (ttm)	4.22
PE Ratio	18.25
Forward PE	15.46
Dividend	1.25 (1.62%)
Ex-Dividend Date	Nov 12, 2024

Volume	136,325
Open	77.10
Previous Close	77.00
Day's Range	76.80 - 79.50
52-Week Range	76.10 - 121.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About Al-Dawaa Medical Services Company

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marke...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2023, Al-Dawaa Medical Services Company's revenue was 5.74 billion, an increase of 6.87% compared to the previous year's 5.37 billion. Earnings were 329.22 million, an increase of 7.78%.